The NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, shown from interim analysis of its Phase III study data, including effectiveness against the new variants of concern.
Durham Tees Valley Research Alliance has joined the fight against coronavirus by recruiting COVID-19 patients to participate in a ground-breaking new study.
The Research and Innovation Team at South Tees Hospitals NHS Foundation Trust recruited a record number of patients to take part in clinical trials last year. In 2017/18 the team recruited 3,758 patients to clinical research trials – a 9% increase on the previous year. The impressive figure places South Tees among the top 10% of all NHS trusts across the country when it comes to research recruitment.
Researchers in health and education are leading a new trial that aims to reduce patients’ dependency on strong pain killers. South Tees Hospitals NHS Foundation Trust and the University of Warwick have developed a support programme that they hope will help people with long term pain reduce their dependency on opioids and improve their quality of life.